We are live on ! Find out more

21 hedge funds and large institutions have $818K invested in Imunon in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.47% less ownership

Funds ownership: 0.99%0.53% (-0.47%)

13% less funds holding

Funds holding: 2421 (-3)

51% less capital invested

Capital invested by funds: $1.69M → $818K (-$868K)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
7
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q3 2022 in Review

21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2022, worth a combined $818K — down 51% from $1.69M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IMNN and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $69K. The largest seller was Murchinson, exiting entirely with an estimated $509K sold.

  • 21 institutional investors held Imunon (IMNN) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $818K of Imunon stock for Q3 2022, down 51% quarter-over-quarter.
  • 2 funds opened new Imunon positions in Q3 2022 and 5 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q3 2022 was Citadel Advisors, an estimated $69K added.
  • The largest Imunon seller in Q3 2022 was Murchinson, an estimated $509K sold.

Based on aggregated 13F filings for Q3 2022.